http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2253675-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
| filingDate | 2001-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d12d57b2274bb5f8b5f8b66a9f14dc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93aa109925b4b68e767571d07d6c4764 |
| publicationDate | 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2253675-C2 |
| titleOfInvention | Bacteriophage strain helicobacter pylori with lytic activity in relation to bacteria helicobacter pylori and method for production of antigastritis and antiulcer drug based on the same |
| abstract | FIELD: medical virology and microbiology. n SUBSTANCE: new bacteriophage strain Helicobacter pylori, having lytic activity is disclosed. Method for production of antigastritis and antiulcer drug based on the new bacteriophage strain also is disclosed. Claimed method includes providing of purified suspension of bacteriophage Helicobacter pylori with lytic activity of 10 9 FFU/ml and addition of 1 % chinozole thereto. Moreover sorbitole and gelatose also may be introduced into said agent. Obtained mixture is frozen and lyophilized. n EFFECT: high effective antigastritis and antiulcer drug useful in medicine. n 3 cl, 1 tbl, 2 ex |
| priorityDate | 2001-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.